Linking Statins to the Suppression of Aggressive Phenotypes of Triple-Negative Breast Cancer Cells

Host: Matt Birnholz, MD

Guest: Stephen Hiscox, PhD

Though statins have long been used for the treatment of hypercholesterolemia, growing evidence suggests they may also have a role in lowering the risk of breast cancer development. But how they potentially do this and whether all statins are equal to that task was the focus of Dr. Matt Birnholz’s discussion with Dr. Stephen Hiscox at the 2019 San Antonio Breast Cancer Symposium.